Tags

Type your tag names separated by a space and hit enter

The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease.
Urology. 2016 Jan; 87:76-81.U

Abstract

OBJECTIVE

To investigate the effect of percutaneous posterior tibial nerve stimulation (PTNS) treatment after 12 weeks on urodynamic and clinical findings in patients with Parkinson's disease (PD) with neurogenic detrusor overactivity.

METHODS

A total of 47 patients with PD with neurogenic detrusor overactivity were enrolled in the study. Urodynamic studies before and after 12-week PTNS treatment were performed. International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF), Overactive Bladder Questionnaire (OAB-V8), and Overactive Bladder Questionnaire Short Form (OAB-q SF) have been assessed before and after PTNS treatment.

RESULTS

The mean first involuntary detrusor contraction volume (1st IDCV) on standard cystometry was 133.2 ± 48.1 (24-265) mL, whereas it was 237.3 ± 43.1 (145-390) mL after PTNS. The mean maximum cystometric capacity (MCC) on standard cystometry was 202.2 ± 36.5 (115-320) mL, whereas it was 292.1 ± 50.6 (195-395) mL after stimulation. The improvements in the first involuntary detrusor contraction volume and maximum cystometric capacity were statistically significant after stimulation. The mean Pdetmax at first involuntary detrusor contraction, maximal detrusor pressure at maximum cystometric capacity, PdetQmax, Qmax, and post-void residual volume were statistically significant after 12-week stimulation. Mean parametric improvements at 12-week PTNS treatment from baseline included daytime frequency decreased by 5.6 voids daily, urge incontinence decreased by 3.1 episodes daily, urgency episodes decreased by 6.3 episodes daily, nocturia decreased by 2.7 voids, and voided volume improved by a mean of 92.6 mL. The change from baseline on the ICIQ-SF, OABv8, and OAB-q at 12-week PTNS treatment demonstrated statistically significant improvements.

CONCLUSION

These results have demonstrated that PTNS improves the lower urinary tract symptoms and urodynamic parameters in patients with PD.

Authors+Show Affiliations

Department of Urology, Dumlupinar University Faculty of Medicine, Kutahya, Turkey. Electronic address: skabay@yahoo.com.Department of Neurology, Dumlupinar University Faculty of Medicine, Kutahya, Turkey.Department of Urology, Dumlupinar University Faculty of Medicine, Kutahya, Turkey.Department of Urology, Dumlupinar University Faculty of Medicine, Kutahya, Turkey.Department of Urology, Dumlupinar University Faculty of Medicine, Kutahya, Turkey.Department of Neurology, Dumlupinar University Faculty of Medicine, Kutahya, Turkey.Department of Anatomy, Eskisehir Osmangazi University Faculty of Medicine, Eskisehir, Turkey.Department of Neurology, Canakkale 18 Mart University Faculty of Medicine, Canakkale, Turkey.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

26436213

Citation

Kabay, Sahin, et al. "The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation On Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease." Urology, vol. 87, 2016, pp. 76-81.
Kabay S, Canbaz Kabay S, Cetiner M, et al. The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease. Urology. 2016;87:76-81.
Kabay, S., Canbaz Kabay, S., Cetiner, M., Mestan, E., Sevim, M., Ayas, S., Ozden, H., & Ozisik Karaman, H. (2016). The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease. Urology, 87, 76-81. https://doi.org/10.1016/j.urology.2015.09.026
Kabay S, et al. The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation On Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease. Urology. 2016;87:76-81. PubMed PMID: 26436213.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The Clinical and Urodynamic Results of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease. AU - Kabay,Sahin, AU - Canbaz Kabay,Sibel, AU - Cetiner,Mustafa, AU - Mestan,Emine, AU - Sevim,Mehmet, AU - Ayas,Selahattin, AU - Ozden,Hilmi, AU - Ozisik Karaman,Handan, Y1 - 2015/10/05/ PY - 2015/07/15/received PY - 2015/09/15/revised PY - 2015/09/22/accepted PY - 2015/10/6/entrez PY - 2015/10/6/pubmed PY - 2016/6/9/medline SP - 76 EP - 81 JF - Urology JO - Urology VL - 87 N2 - OBJECTIVE: To investigate the effect of percutaneous posterior tibial nerve stimulation (PTNS) treatment after 12 weeks on urodynamic and clinical findings in patients with Parkinson's disease (PD) with neurogenic detrusor overactivity. METHODS: A total of 47 patients with PD with neurogenic detrusor overactivity were enrolled in the study. Urodynamic studies before and after 12-week PTNS treatment were performed. International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF), Overactive Bladder Questionnaire (OAB-V8), and Overactive Bladder Questionnaire Short Form (OAB-q SF) have been assessed before and after PTNS treatment. RESULTS: The mean first involuntary detrusor contraction volume (1st IDCV) on standard cystometry was 133.2 ± 48.1 (24-265) mL, whereas it was 237.3 ± 43.1 (145-390) mL after PTNS. The mean maximum cystometric capacity (MCC) on standard cystometry was 202.2 ± 36.5 (115-320) mL, whereas it was 292.1 ± 50.6 (195-395) mL after stimulation. The improvements in the first involuntary detrusor contraction volume and maximum cystometric capacity were statistically significant after stimulation. The mean Pdetmax at first involuntary detrusor contraction, maximal detrusor pressure at maximum cystometric capacity, PdetQmax, Qmax, and post-void residual volume were statistically significant after 12-week stimulation. Mean parametric improvements at 12-week PTNS treatment from baseline included daytime frequency decreased by 5.6 voids daily, urge incontinence decreased by 3.1 episodes daily, urgency episodes decreased by 6.3 episodes daily, nocturia decreased by 2.7 voids, and voided volume improved by a mean of 92.6 mL. The change from baseline on the ICIQ-SF, OABv8, and OAB-q at 12-week PTNS treatment demonstrated statistically significant improvements. CONCLUSION: These results have demonstrated that PTNS improves the lower urinary tract symptoms and urodynamic parameters in patients with PD. SN - 1527-9995 UR - https://www.unboundmedicine.com/medline/citation/26436213/The_Clinical_and_Urodynamic_Results_of_Percutaneous_Posterior_Tibial_Nerve_Stimulation_on_Neurogenic_Detrusor_Overactivity_in_Patients_With_Parkinson's_Disease_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0090-4295(15)00927-9 DB - PRIME DP - Unbound Medicine ER -